Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 7 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Dermata Therapeutics, Inc. | 37,500 | reported | 02 Jan 2026 | tx 39+6,474,626−36,787,625 |
| TENAX THERAPEUTICS, INC. | 30,000 | reported | 09 Jan 2026 | tx 12+273,862 |
| RITTER PHARMACEUTICALS INC | 30,000 | reported | 23 Jan 2018 | tx 4+97,000 |
| SOPHIRIS BIO INC. | 20,000 | reported | 27 Jun 2019 | tx 8+104,627 |
| DEPOMED INC | 5,000 | reported | 23 Mar 2006 | tx 3+30,000 |
| Auspex Pharmaceuticals, Inc. | 0 | reported | 05 May 2015 | tx 5+8,133−21,466 |
| SANTARUS INC | 0 | reported | 02 Jan 2014 | tx 183+3,784,891−4,779,404 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 09 Jan 2026 | GRANT_AWARD | TENAX THERAPEUTICS, INC. | 3,000 | 0.00 USD | deriv |
| 02 Jan 2026 | GRANT_AWARD | Dermata Therapeutics, Inc. | 37,500 | 0.00 USD | deriv |
| 23 Dec 2025 | GRANT_AWARD | Dermata Therapeutics, Inc. | 122,549 | — | |
| 23 Dec 2025 | GRANT_AWARD | Dermata Therapeutics, Inc. | 490,196 | — | |
| 23 Dec 2025 | GRANT_AWARD | Dermata Therapeutics, Inc. | 490,196 | — | deriv |
| 23 Dec 2025 | GRANT_AWARD | Dermata Therapeutics, Inc. | 490,196 | — | deriv |
| 23 Dec 2025 | GRANT_AWARD | Dermata Therapeutics, Inc. | 122,549 | — | deriv |
| 23 Dec 2025 | GRANT_AWARD | Dermata Therapeutics, Inc. | 122,549 | — | deriv |
| 23 Dec 2025 | GRANT_AWARD | Dermata Therapeutics, Inc. | 78,740 | — | deriv |
| 23 Dec 2025 | OTHER | Dermata Therapeutics, Inc. | 78,740 | — | deriv |
| 01 Jul 2025 | GRANT_AWARD | TENAX THERAPEUTICS, INC. | 80,000 | 0.00 USD | deriv |
| 21 Jan 2025 | GRANT_AWARD | Dermata Therapeutics, Inc. | 787,402 | — | |
| 21 Jan 2025 | GRANT_AWARD | Dermata Therapeutics, Inc. | 787,402 | — | deriv |
| 13 Jan 2025 | GRANT_AWARD | Dermata Therapeutics, Inc. | 45,000 | 0.00 USD | deriv |
| 10 Dec 2024 | GRANT_AWARD | TENAX THERAPEUTICS, INC. | 100,000 | 0.00 USD | deriv |
| 08 Aug 2024 | PURCHASE | TENAX THERAPEUTICS, INC. | 1,666 | — | first after silence |
| 08 Aug 2024 | PURCHASE | TENAX THERAPEUTICS, INC. | 31,654 | — | deriv |
| 08 Aug 2024 | PURCHASE | TENAX THERAPEUTICS, INC. | 16,660 | — | deriv |
| 04 Jan 2024 | GRANT_AWARD | Dermata Therapeutics, Inc. | 125,000 | 0.00 USD | deriv |
| 09 Jun 2022 | GRANT_AWARD | TENAX THERAPEUTICS, INC. | 5,000 | 0.00 USD | deriv |
| 03 Jan 2022 | GRANT_AWARD | Dermata Therapeutics, Inc. | 197,610 | 0.00 USD | deriv |
| 03 Jan 2022 | GRANT_AWARD | Dermata Therapeutics, Inc. | 57,859 | 0.00 USD | deriv |
| 03 Jan 2022 | GRANT_AWARD | Dermata Therapeutics, Inc. | 42,141 | 0.00 USD | deriv |
| 03 Jan 2022 | GRANT_AWARD | Dermata Therapeutics, Inc. | 4,517 | 0.00 USD | deriv |
| 23 Nov 2021 | PURCHASE | Dermata Therapeutics, Inc. | 20,000 | 2.40 USD |
5 purchases reported after at least 12 months of silence — most recent on 08 Aug 2024.